Literature DB >> 7384803

Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid.

B A Khaw, F T Fallon, H W Strauss, E Haber.   

Abstract

Antibodies, by virtue of marked selectivity and affinity, may lend themselves to identification of structures of unique antigenic specificity in vivo. In experimental myocardial infarction in dogs, F(ab')2 fragments of antibodies to cardiac myosin that had been labeled with iodine-131 were shown to localize within the lesion. Because the energy characteristics of iodine isotopes are not ideal for imaging with a gamma camera, a new method for labeling antibody fragments with divalent or polyvalent radionuclides was developed. A bifunctional chelating agent, diethylenetriamine pentaacetic acid was covalently coupled, by an amide bond, to Fab fragments of antibodies to canine cardiac myosin. A stable chelate was then formed with indium-111, a nuclide that has appropriate half-life and energy characteristics for gamma imaging. Antibodies treated in this way retain their antigen-binding activity and are useful in locating myocardial infarcts in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7384803     DOI: 10.1126/science.7384803

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  32 in total

1.  Noninvasive detection of cell death: from tracking epitaphs to counting coffins.

Authors:  Jagat Narula; Barry L Zaret
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

2.  Myocardial uptake of antimyosin antibody compared with serum myosin light chain I levels in patients with myocardial infarction.

Authors:  M Suehiro; M Fukuchi; H Naruse; T Iwasaki
Journal:  Ann Nucl Med       Date:  1992-02       Impact factor: 2.668

Review 3.  Antibodies for molecular imaging in the cardiovascular system.

Authors:  Ban-An Khaw
Journal:  J Nucl Cardiol       Date:  2005 Sep-Oct       Impact factor: 5.952

Review 4.  Clinical role of indium-111 antimyosin imaging.

Authors:  S Bhattacharya; A Lahiri
Journal:  Eur J Nucl Med       Date:  1991

5.  Indium-111 myosin-specific antibodies and technetium-99m pyrophosphate in the detection of acute cardiac rejection of transplanted hearts: studies in a heterotopic rat heart model.

Authors:  K Takeda; K Ueda; U Scheffel; H Ravert; N D LaFrance; W A Baumgartner; B A Reitz; A Herskowitz; H N Wagner
Journal:  Eur J Nucl Med       Date:  1991

6.  Antimyosin antibody imaging in experimental aortic regurgitation.

Authors:  P Lu; P Zanzonico; S M Goldfine; R Hardoff; N Magid; R Gentile; E M Herrold; J S Borer
Journal:  J Nucl Cardiol       Date:  1997 Jan-Feb       Impact factor: 5.952

7.  Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.

Authors:  R W Kozak; R W Atcher; O A Gansow; A M Friedman; J J Hines; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

8.  Technetium-99m antimyosin antibody (3-48) myocardial imaging: human biodistribution, safety and clinical results in detection of acute myocardial infarction.

Authors:  R Taillefer; L Boucher; R Lambert; J Grégoire; D C Phaneuf; H Sikorsa
Journal:  Eur J Nucl Med       Date:  1995-05

9.  Production of carrier-free 66Ga and labeling of antimyosin antibody for positron imaging of acute myocardial infarction.

Authors:  P Goethals; M Coene; G Slegers; D Vogelaers; J Everaert; I Lemahieu; F Colardyn; G R Heyndrickx
Journal:  Eur J Nucl Med       Date:  1990

10.  Human breast tumor imaging using 111In labeled monoclonal antibody: athymic mouse model.

Authors:  B A Khaw; J S Bailes; S L Schneider; J Lancaster; J Powers; H W Strauss; J C Lasher; W L McGuire
Journal:  Eur J Nucl Med       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.